ChemoCentryx Inc reports results for the quarter ended in March - Earnings Summary

Churchill Capital XI

05/05/2022 23:22

* ChemoCentryx Inc  CCXI.OQ  reported a quarterly adjusted
loss
of 55 cents​​ per share for the quarter ended in March. The mean
expectation of eight analysts for the quarter was for a loss
of 31 cents per share.
    * Revenue fell 47.3% to $5.46 million from a year ago; 
analysts
expected $21.37 million. 
    * ChemoCentryx Inc's reported EPS for the quarter was a loss
of 55
cents​.
    * The mean earnings estimate of analysts had risen by
about 35.4%
in the last three months.​ 
    * In the last 30 days two analysts negatively revised
earnings
estimates 
    * ChemoCentryx Inc shares had fallen by 32.2% this
quarter and
lost 53.3% so far this year.
    * The company reported a quarterly loss of $38.61 million.
    * Wall Street's median 12-month price target for
ChemoCentryx Inc
is $65.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 10:22 p.m.  ​All
figures in US dollars unless otherwise stated